Respironics grows sleep disorder business with Apollo buy:
This article was originally published in Clinica
Sleep and respiratory treatment specialist Respironics has expanded its reach in the sleep disorder therapy market with the purchase of Apollo Light Systems for $6.5m. Murrysville, Pennsylvania-based Respironics, which is looking to broaden its scope beyond its core business of treating obstructive sleep apnea, will add Apollo's light therapy systems for melatonin suppression and circadian rhythm sleep disorders to its Sleep Well Ventures business. The deal will see additional payments made by Respironics to Apollo based on the latter's operating performance over the next year. Apollo (American Fork, Utah) generates annual revenues of around $5m from sales of its briteLITE and goLITE light therapy systems and its Daybreak Sunrise simulators.